143113-45-5

Basic information

• Product Name: BQ-3020
• Synonyms: N-AC, ALA11,15-ENDOTHELIN 1, 6-21;N-ACETYL[ALA11,15]-ENDOTHELIN-1 (6-21);N-ACETYL-[ALA11,15]ENDOTHELIN-I (6-21);BQ-3020;ENDOTHELIN-1(6-21), N-ACETYL-[ALA11,15]-;AC-(ALA11,15)-ENDOTHELIN-1 (6-21);ACETYL-(ALA11,15)-ENDOTHELIN-1 (6-21);ACETYL-LEU-MET-ASP-LYS-GLU-ALA-VAL-TYR-PHE-ALA-HIS-LEU-ASP-ILE-ILE-TRP-OH
• CAS NO: 143113-45-5
• Molecular Formula: C96H140N20O25S
• Molecular Weight: 2006.34
• Product Categories: Endothelin receptor
• Mol File: 143113-45-5.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 2125.8±65.0 °C(Predicted)
• Appearance: white/powder
• Density: 1.287±0.06 g/cm3(Predicted)
• Storage Temp.: −20°C
• PKA: 3.39±0.10(Predicted)
• Sensitive: Light Sensitive
• CAS DataBase Reference: BQ-3020(CAS DataBase Reference)
• NIST Chemistry Reference: BQ-3020(143113-45-5)
• EPA Substance Registry System: BQ-3020(143113-45-5)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 143113-45-5(Hazardous Substances Data)

Usage

General Description

BQ-3020 is a patented chemical compound developed by Bluequark Pharmaceuticals. It is a novel small molecule inhibitor that targets a specific protein involved in cancer cell proliferation and survival. The compound has shown promising results in preclinical studies, demonstrating potent anti-cancer activity and minimal toxicity. BQ-3020 is currently being evaluated in clinical trials for its potential as a targeted therapy for various types of cancer. Its unique mechanism of action and favorable safety profile make it a promising candidate for the development of new anti-cancer treatments.